Bone marrow mesenchymal stem cell transplantation via different approaches in treatment of liver cirrhosis in mice

Zhang LiXia; Li Ying; Wang LiMing; Yan Xiang

doi:10.3969/j.issn.1001-5256.2016.10.016

Issue 10

Oct. 2016

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2016 > 32(10): 1906-1910

PDF( 2218 KB)

Bone marrow mesenchymal stem cell transplantation via different approaches in treatment of liver cirrhosis in mice

DOI: 10.3969/j.issn.1001-5256.2016.10.016

Second Department of Cardre, The First Hospital of Lanzhou University

Research funding:

Published Date: 2016-10-20

Abstract

Abstract

Objective To investigate the clinical effects of bone marrow mesenchymal stem cell( BMSC) transplantation via different approaches in the treatment of liver cirrhosis in mice. Methods A total of 46 BALB / c mice were randomly divided into normal control group with 5 mice and liver cirrhosis model group with 41 mice. Subcutaneously injected carbon tetrachloride olive oil was used to establish the mouse model of liver cirrhosis. A total of 36 mice with liver cirrhosis were randomly divided into control group,caudal vein BMSC transplantation group,and spleen BMSC transplantation group,with 12 mice in each group. Whole bone marrow adherent culture was performed to obtain the third-generation BMSCs,and flow cytometry was used for cell surface identification. BMSCs were injected into the mice through the caudal vein or spleen. Blood samples were collected at 4 weeks after transplantation to measure liver function. HE and Masson staining and α-smooth muscle actin( α-SMA) immunohistochemistry were performed for liver sections. Liver injury and fibrosis in mice were examined. A one-way analysis of variance was used for comparison between groups. Results At 8 weeks after the establishment of the model,the mice in the model group had sparse and dark yellow hair,reduced food consumption and activity,and a reduction in body weight.After transplantation,compared with the model control group,the caudal vein BMSC transplantation group and spleen BMSC transplantation group showed a significant increase in albumin and significant reductions in alanine aminotransferase and aspartate aminotransferase( all P<0. .="" there="" were="" no="" significant="" differences="" between="" the="" two="" transplantation="" p="">0. 05). After transplantation,there were significant changes in diseased tissue,alleviated liver cirrhosis,reduced collagen fiber and necrotic area,and a good structure. Immunohistochemistry showed both transplantation groups showed significant reductions in the number of cells with positive α-SMA. Conclusion BMSC transplantation via the tail vein or spleen can improve liver function and diseased tissue in mice with liver cirrhosis and these two approaches have comparable clinical effects.
- liver cirrhosis,
- mesenchymal,
- stem cells

FullText(HTML)

References(18)

References

[1]NIEMEYER P,KORNACKER M,MEHLHORN A.Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after Osteogenic differentiation in vitro[J].Tissue Eng,2007,13(1):111-121.

[2]LEBLANC K,RINGDEN O.Immunomodulation by mesenchymal stem cells and clinical experience[J].Intern Med,2007,262(5):509-525.

[3]KHARAZIHA P,HELLSTROM PM,NOORINAYER B,et al.Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection:a phase I-II clinical trial[J].Eur J Gastroenterol Hepatol,2009,21(10):1199-1205.

[4]PAI M,SPALDING D,XI F,et al.Autologous bone marrow stem cells in the treatment of chronic liver disease[J].Int J Hepatol,2012,2012:307165.

[5]LI B,DONG QS,JI D,et al.Mesenchymal stem cells mitigate cirrhosis through BMP7[J].Cell Physiol Biochem,2015,35(2):433-440.

[6]ALHADLAQ A,MAO JJ.Mesenchymal stem cells:isolation and therapeutics[J].Stem Cells Dev,2004,13(4):436-448.

[7]KIM MY,CHO MY,BAIK SK,et al.Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension[J].J Hepatol,2011,55(5):1004-1009.

[8]CALVARUSO V,BURROUGHS AK,STANDISH R,et al.Computer-assisted image analysis of liver collagen:relationship to Ishak scoring and hepatic venous pressure gradient[J].Hepatology,2009,49(4):1236-1244.

[9]SALAMA H,ZEKRI AR,AHMED R,et al.Assessment of health-related quality of life in patients receiving stem cell therapy for end-stage liver disease:an egyptian study[J].Stem Cell Res Ther,2012,3(6):49.

[10]COUTO BG,GOLDENBERG RC,THOMAST J,et al.Bone marrow mononuclear cell therapy for patients with cirrhosis:a phase 1study[J].Liver Int,2011,31(3):391-400.

[11]MOHAMADNE M,NAMIRI M,BAGHERI M,et al.Phase 1 human trail of autologous bone marrow-hematopoietic stem cell transplantation in patients with decornpensated cirrhosis[J].World J Gastroenterol,2007,13(24):3359-3363.

[12]ZHAO KY,WANG HS,HOU MX,et al.The effect of different numbers of bone marrow mesenehymal stem cells transplanted into rats with pulmonary arterial hypertension and their influence on endothelin-1 expression[J].Chin J Clin Thoracic Cardiov Surg,2012,19(3):298-303.(in Chinese)赵科研,王辉山,侯明晓,等.不同数目骨髓间充质干细胞移植对大鼠肺动脉高压的作用及内皮素-1表达的影响[J].中国胸心血管外科临床杂志,2012,19(3):298-303.

[13]WANG T,TANG W,SUN S,et al.Intravenous infusion of bone marrow mesenchymal stem cells improves myocardial function in a rat model of myocardial ischemia[J].Crit Care Med,2007,35(11):2587-2593.

[14]MA ZZ,LU LG.New advances in drug therapies for liver fibrosis[J].J Clin Hepatol,2016,32(6):1183-1187.(in Chinese)马振增,陆伦根.肝纤维化药物治疗的新进展[J].临床肝胆病杂志,2016,32(6):1183-1187.

[15]TANG WP,AKAHOSHI T,PIAO JS,et al.Basic fibroblast growth factor-treated adipose tissue-derived mesenchymal stem cell infusion to ameliorate liver cirrhosis via paracrine hepatocyte growth factor[J].J Gastroenterol Hepatol,2015,30(6):1065-1074.

[16]JANG YO,KIM MY,CHO MY,et al.Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model[J].BMC Gastroenterology,2014,14:198.

[17]ZHANG JH,JIANG HX,MENG YC,et al.HGF from bone marrow mesenchymal stem cells paracrine up-regulate the expression of DR5 and caspase-8 in rat hepatic stellate cells[J].Basic Clin Med,2012,32(7):804-808.(in Chinese)张君红,姜海行,孟云超,等.大鼠骨髓间充质干细胞旁分泌HGF上调肝星状细胞DR5及caspase-8的表达[J].基础医学与临床,2012,32(7):804-808.

[18]CHAMBERLAIN J,YAMAGAMI T,COLLETTI E,et al.Efficient generation of human hepatocytes by the intrahepatic delivery of clonal human mesenchymal stem cells in fetal sheep[J].Hepatology,2007,46(6):1935-1945.

Relative Articles

[1]	Xinrui ZHENG, Yannan XU, Danyang WANG, Feifei XING, Mengyao ZONG, Shihao ZHANG, Junyi ZHAN, Wei LIU, Gaofeng CHEN, Jiamei CHEN, Ping LIU, Yongping MU. Therapeutic effect of transplantation of bone marrow mesenchymal stem cells co-cultured with bone marrow M2 macrophages on a rat model of liver cirrhosis[J]. Journal of Clinical Hepatology, 2024, 40(1): 96-103. doi: 10.12449/JCH240117
[2]	Yingqi QIU, Hongwei WANG, Hongyan ZHU, Hongliang YU, Fan XIE, Cuibao JIANG. Efficacy of human umbilical cord mesenchymal stem cells via different transplantation approaches in treatment of rats with liver cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(12): 2851-2857. doi: 10.3969/j.issn.1001-5256.2023.12.016
[3]	Group of Stem Cell Engineering, Medical Engineering Society of Chinese Medical Association. Expert consensus on standardized treatment of decompensated liver cirrhosis with stem cell transplantation (2021)[J]. Journal of Clinical Hepatology, 2021, 37(7): 1540-1544. doi: 10.3969/j.issn.1001-5256.2021.07.012
[4]	You Kun, Wang DaJun, Wang Liang, Wang JianGuo. Effect of NOR1 gene knockout on nude mice xenograft tumor of human liver cancer and its mechanism of action[J]. Journal of Clinical Hepatology, 2020, 36(2): 381-386. doi: 10.3969/j.issn.1001-5256.2020.02.030
[5]	Gao YuDi, Tian Yuan, Zhang XiangYing, Zhang XiaoHui, Duan ZhongPing, Ren Feng, Chen Yu. Effect of magnesium isoglycyrrhizinate on concanavalin A-induced acute liver failure in mice[J]. Journal of Clinical Hepatology, 2020, 36(7): 1571-1576. doi: 10.3969/j.issn.1001-5256.2020.07.024
[6]	Lu Xin, Liu Ying, Jia Lei, Kong LingYu, Liu DianQing. Role of D-bifunctional protein in promoting the growth of hepatocellular carcinoma in rats and nude mice[J]. Journal of Clinical Hepatology, 2019, 35(7): 1532-1535. doi: 10.3969/j.issn.1001-5256.2019.07.022
[7]	Yu JiaJian, Zhang JunYong, Fan DeQing. Influence of monoacylglycerol lipase on growth of nude mice xenograft tumor of human hepatocellular carcinoma and related mechanism[J]. Journal of Clinical Hepatology, 2019, 35(7): 1525-1531. doi: 10.3969/j.issn.1001-5256.2019.07.021
[8]	Zhang YiTong, Xin Lei, Li ZhaoShen. Research advances in mesenchymal stem cells in treatment of end-stage liver disease and their application prospect[J]. Journal of Clinical Hepatology, 2019, 35(9): 2104-2107. doi: 10.3969/j.issn.1001-5256.2019.09.049
[9]	Ma ShiChao, Zhang ChaoQun, Sun DianXing. Clinical effect of topical application of CpG oligodeoxynucleotide combined with OX40 monoclonal antibody for mouse model of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2019, 35(9): 1985-1989. doi: 10.3969/j.issn.1001-5256.2019.09.020
[10]	Wu LinLan, Xu Bing, Wei JianWei, Zhao ZhiPing, Huang SuQin, Yang XiaoMei. Therapeutical effect of local transplantation of bone marrow mesenchymal stem cells mixed with fibrin gel on rats with liver injury[J]. Journal of Clinical Hepatology, 2018, 34(8): 1740-1744. doi: 10.3969/j.issn.1001-5256.2018.08.029
[11]	Lai JieYing, Song SiYu, Hao LiPing, Zhang XiaoLi. Localization and therapeutic effect of bone marrow hematopoietic cell transplantation in rat model of liver fibrosis[J]. Journal of Clinical Hepatology, 2015, 31(11): 1878-1882. doi: 10.3969/j.issn.1001-5256.2015.11.026
[12]	Sun HaiQing, Wang XiaoQi, Shi HongBo, Lou JinLi, Chen Yu, Duan ZhongPing. Ganshuang granules protect mouse liver from chronic injury induced by CCl4 via autophagy[J]. Journal of Clinical Hepatology, 2015, 31(7): 1114-1119. doi: 10.3969/j.issn.1001-5256.2015.07.028
[13]	Shang JianZhong, Ma LongFei, Ma HongWei, Zhao QiuFang, Zhao LinHua, Li XiaoFei, Fan YanFeng, Zhang SuE. Effect of autologous bone marrow- derived mesenchymal stem cells on portal hemodynamics in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2013, 29(11): 848-851. doi: 10.3969/j.issn.1001-5256.2013.10.012
[14]	Shao XiaoDong, Guo XiaoZhong, Wang Di, Zou DeLi, Ren LiNan, Li HongYu, Zhao JiaJun. The effects of CD34+ cell on the efficacy of autologous bone marrow stem cell transplantation in patients with cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(2): 127-129.
[15]	Lu: SuLi, Ma Yong, Ding TiLong. Bone marrow mesenchymal stem cells as therapy for hepatic fibrosis[J]. Journal of Clinical Hepatology, 2012, 28(11): 819-823.
[16]	Tang Wen, Jiang MingDe. Clinical studies of stem cell transplantation to treat liver cirrhosis [J]. Journal of Clinical Hepatology, 2012, 28(10): 735-737.
[17]	Lu KunYun, Yang JinHui. Comparison of the various approaches of stem cell transplantation in liver cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(11): 1226-1228+1232.
[18]	Jiang Jun, Fan Ping, Li DongLiang, Chen ShiXiang, Wang MengYan, He XiuHua, He WeiXin, Xu TingTing, Chen XiQing, Xiong ZhiYuan, He ZhiCheng, Xiao BingMin. Autologous stem cells transplantation for treatment of decompensate liver cirrhosis in 40 cases[J]. Journal of Clinical Hepatology, 2010, 26(6): 610-612.
[19]	Gao YuanZheng, Jia SuHua, Liu YuYing, Zhang ShouMin, Wang Yan, Zhao LianFeng, Wei XingHui. Efficacy of allogeneic umbilical cord blood stem cell transplantation for treatment of decompensated cirrhosis[J]. Journal of Clinical Hepatology, 2010, 26(6): 613-614+617.
[20]	Li ShuangXing, Shi LiJun, Wang XiuJie. Effects of bone marrow mesenchymal stem cells transplantation into rats with acute liver failure[J]. Journal of Clinical Hepatology, 2010, 26(6): 624-626.

Supplements(0)

Cited By

Cited by

Periodical cited type(4)

1.	马刚，郑小红，王敬博，韩英. 间充质干细胞移植不同的途径可影响肝纤维化治疗效果. 中国组织工程研究. 2023(19): 3099-3107 .
2.	穆丽雅，唐秀芬，李淑芹，于丹，孙媛媛，赵金花. 不同途径移植骨髓干细胞治疗急性肝损伤小鼠模型的效果比较. 临床肝胆病杂志. 2019(01): 153-156 . 本站查看
3.	王邓，孙航，吴传新. 自体骨髓干细胞治疗肝硬化的应用及管理. 临床肝胆病杂志. 2019(04): 895-898 . 本站查看
4.	肖笑枭，梁锐. 干细胞移植治疗慢加急性肝衰竭的研究进展. 临床肝胆病杂志. 2017(08): 1576-1580 . 本站查看

Other cited types(2)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2580) PDF downloads(431)

Bone marrow mesenchymal stem cell transplantation via different approaches in treatment of liver cirrhosis in mice

DOI: 10.3969/j.issn.1001-5256.2016.10.016